Browse 3 Therapeutics companies funded by Draper Associates. See funding amounts, founder contacts, and investment details.
HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.
Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.
View all companies funded by Draper Associates across every industry and funding stage.
View Full Draper Associates Portfolio